FRNM Freenome Inc
Which ETFs hold FRNM? Freenome Inc is held by 1 fund tracked by ETFpeek.
HealthcareDiagnostics & Research
$12.48
+16.6% 1y
$9.9552-week range$17.50
Market cap
$1.3B
3-month
+11.9%
CEO
Mr. Aaron Elliott Ph.D.
Revenue growth (YoY)
+106.5%
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.
Provider
Currently Held By
Not held by the selected provider.
Insider Activity
last 90 daysNo insider activity recorded in the last 90 days.
Trade History
20 trades| Date | Fund | Direction | Shares Changed | % Δ ETF | % Δ Position |
|---|---|---|---|---|---|
| 26 Oct 2026 | ARKG | BUYAdded | +169,465 | +0.06% | 8.92% |
| 23 Oct 2026 | ARKG | BUYAdded | +35,374 | +0.00% | 2.23% |
| 19 Oct 2026 | ARKG | BUYAdded | +255,096 | +0.12% | 15.54% |
| 16 Oct 2026 | ARKG | BUYAdded | +25,266 | +0.00% | 0.99% |
| 15 Oct 2026 | ARKG | BUYAdded | +110,026 | +0.04% | 8.35% |
| 14 Oct 2026 | ARKG | BUYAdded | +84,649 | +0.04% | 7.20% |
| 13 Oct 2026 | ARKG | BUYAdded | +136,894 | +0.00% | 12.64% |
| 12 Oct 2026 | ARKG | BUYAdded | +14,988 | -0.02% | 1.59% |
| 9 Oct 2026 | ARKG | BUYAdded | +67,305 | +0.05% | 7.25% |
| 8 Oct 2026 | ARKG | BUYAdded | +39,983 | +0.04% | 4.56% |
| 7 Oct 2026 | ARKG | BUYAdded | +35,591 | +0.07% | 4.24% |
| 6 Oct 2026 | ARKG | BUYAdded | +47,085 | +0.02% | 5.76% |
| 27 Aug 2026 | ARKG | BUYAdded | +14,542 | +0.01% | 1.92% |
| 25 Aug 2026 | ARKG | BUYAdded | +12,939 | +0.02% | 1.76% |
| 24 Aug 2026 | ARKG | BUYAdded | +15,995 | +0.00% | 2.21% |
| 21 Aug 2026 | ARKG | BUYAdded | +46,145 | +0.03% | 6.85% |
| 20 Aug 2026 | ARKG | BUYAdded | +55,170 | +0.00% | 8.71% |
| 19 Aug 2026 | ARKG | BUYAdded | +59,280 | +0.07% | 10.52% |
| 18 Aug 2026 | ARKG | BUYAdded | +144,595 | +0.14% | 28.63% |
| 17 Aug 2026 | ARKG | BUYNew position | +360,470 | +0.24% | 100.00% |
| No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal. | |||||